Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
Total Valuation
Aroa Biosurgery Ltd has a market cap or net worth of AU$200.12M. The enterprise value is AU$198.69M.
Market CapAU$200.12M
Enterprise ValueAU$198.69M
Share Statistics
Aroa Biosurgery Ltd has 345,033,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding345,033,230
Owned by Insiders0.47%
Owned by Institutions―
Financial Efficiency
Aroa Biosurgery Ltd’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -10.53%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-10.53%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.78
Inventory Turnover1.46
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio2.39
Price to Fair Value1.73
Price to FCF-45.43
Price to Operating Cash Flow-85.24
PEG Ratio-1.74
Income Statement
In the last 12 months, Aroa Biosurgery Ltd had revenue of 76.97M and earned -3.47M in profits. Earnings per share was -0.01.
Revenue76.97M
Gross Profit65.99M
Operating Income-8.13M
Pretax Income-2.95M
Net Income-3.47M
EBITDA2.65M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.37M and capital expenditures -2.11M, giving a free cash flow of -4.48M billion.
Operating Cash Flow-2.37M
Free Cash Flow-4.48M
Free Cash Flow per Share-0.01
Dividends & Yields
Aroa Biosurgery Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-4.92%
50-Day Moving Average0.51
200-Day Moving Average0.56
Relative Strength Index (RSI)59.86
Average Volume (3m)187.48K
Important Dates
Aroa Biosurgery Ltd upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Aroa Biosurgery Ltd as a current ratio of 6.62, with Debt / Equity ratio of 6.89%
Current Ratio6.62
Quick Ratio5.81
Debt to Market Cap0.00
Net Debt to EBITDA-0.54
Interest Coverage Ratio-7.34
Taxes
In the past 12 months, Aroa Biosurgery Ltd has paid 511.63K in taxes.
Income Tax511.63K
Effective Tax Rate-0.17
Enterprise Valuation
Aroa Biosurgery Ltd EV to EBITDA ratio is 54.85, with an EV/FCF ratio of -25.49.
EV to Sales1.89
EV to EBITDA54.85
EV to Free Cash Flow-25.49
EV to Operating Cash Flow-62.25
Balance Sheet
Aroa Biosurgery Ltd has AU$20.13M in cash and marketable securities with AU$5.83M in debt, giving a net cash position of -AU$14.30M billion.
Cash & Marketable SecuritiesAU$20.13M
Total DebtAU$5.83M
Net Cash-AU$14.30M
Net Cash Per Share-AU$0.04
Tangible Book Value Per ShareAU$0.19
Margins
Gross margin is 85.74%, with operating margin of -10.56%, and net profit margin of -4.50%.
Gross Margin85.74%
Operating Margin-10.56%
Pretax Margin-3.84%
Net Profit Margin-4.50%
EBITDA Margin3.44%
EBIT Margin-2.40%
Analyst Forecast
The average price target for Aroa Biosurgery Ltd is AU$0.82, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$0.82
Price Target Upside41.38% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast20.36%
EPS Growth Forecast64.81%